Lotrafiban: an oral platelet glycoprotein IIb/IIIa blocker

Author： Liu F.   Craft R.M.   Morris S.A.   Carroll R.C.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.11, 2000-11, pp. : 2673-2687

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Platelet glycoprotein IIb/IIIa receptor antagonists

By Casserly I.P.   Moliterno D.J.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 3, 2000-03 ,pp. : 419-433

Informa Healthcare

Access to resources Recommend Favorite

Oral glycoprotein IIb/IIIa antagonists unsuccessful

By  

Inpharma, Vol. 1, Iss. 1345, 2002-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Is there a role for oral blockade of platelet glycoprotein IIb/IIIa receptors in coronary and cerebrovascular disease?

By Salam Amar M  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 10, 2003-10 ,pp. : 1709-1712

Informa Healthcare

Access to resources Recommend Favorite

Abciximab (Reopro): a clinically effective glycoprotein IIb/IIIa receptor blocker

By de Belder M.   Sutton A.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 10, 1998-10 ,pp. : 1701-1717

Informa Healthcare

Access to resources Recommend Favorite

Potential Role of Platelet Glycoprotein IIb/IIIa Antagonists in Cerebrovascular Disorders

By Mousa S.A.  

CNS Drugs, Vol. 13, Iss. 3, 2000-03 ,pp. : 155-160

Adis International

Access to resources Recommend Favorite